Company Search:
Advanced Search
Sponsored Links
Clinuvel Pharmaceuticals Limited - ADR Company Snapshot
Clinuvel Pharmaceuticals Limited operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Clinuvel Pharmaceuticals Limited with three other companies in this sector in UNITED STATES : Kalvista Pharmaceuticals Inc (2020 sales of $12.69 million of which 100% was Pharmaceuticals), Predictive Technology Group Inc ($24.44 million of which 99% was s), and Mesoblast Ltd ($32.16 million of which 100% was Adult Stem Cell Development).

Sales Analysis. During the year ended June of 2020, sales at Clinuvel Pharmaceuticals Limited were $22.20 million. This is a decrease of 1.7% versus 2019, when the company's sales were $22.59 million.
  Stock Performance Chart for Clinuvel Pharmaceuticals Limited - ADR
  Stock Data: Recent Stock Performance:
  Current Price (11/27/2020): 15.17
(Figures in U.S. Dollars)
1 Week 2.4%   13 Weeks 4.7%  
4 Weeks 0.5%   52 Weeks -19.2%  
Clinuvel Pharmaceuticals Limited - ADR Key Data:
  Ticker: CLVLY Country: United States
  Exchanges: OTC Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2020 Sales 22,204,940
(Year Ending Jan 2021).
Employees: 16
  Currency: U.S. Dollars Market Cap: 749,594,356
  Fiscal Yr Ends: June Shares Outstanding: 49,410,338
  Share Type: Ordinary Closely Held Shares: 11,571,665
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.